Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Arun Rajan's publication output changed over time?
ScholarIQpublication output · 2011–2021
Output grew0% over the shown period — from 1 works in 2011 to 1 in 2021.
1
2
3
1
1
1
1
2011201520172018201920202021
What are the most-cited papers on Arun Rajan?
ScholarIQmost cited works
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
Alexander Marx, John K.C. Chan, Lara Chalabreysse, Sanja Đačić, Frank Detterbeck, Christopher A. French, Jason L. Hornick, Hiroshi Inagaki, Deepali Jain, Alexander J. Lazar, Mirella Marino, Edith M. Marom, André L. Moreira, Andrew G. Nicholson, Masayuki Noguchi, Daisuke Nonaka, Mauro Papotti, Štefan Porubský, Lynette M. Sholl, Hisashi Tateyama, Vincent de Montpréville, William D. Travis, Arun Rajan, Anja C. Roden, Philipp Ströbel
Journal of Thoracic Oncology. 2021343 CitationsOPEN ACCESS
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
Anish Thomas, Arun Rajan, Arlene Berman, Yusuke Tomita, Christina Brzezniak, Min-Jung Lee, Sunmin Lee, Alexander Ling, Aaron John Spittler, Corey A. Carter, Udayan Guha, Yisong Wang, Éva Szabó, Paul S. Meltzer, Seth M. Steinberg, Jane B. Trepel, Patrick J. Loehrer, Giuseppe Giaccone
The Lancet Oncology. 2015301 CitationsOPEN ACCESS
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial
Christopher R. Heery, Geraldine O’Sullivan Coyne, Ravi A. Madan, Lisa M. Cordes, Arun Rajan, Myrna Rauckhorst, Elizabeth Lamping, Israel Oyelakin, Jennifer L. Marté, Lauren M. Lepone, Renee N. Donahue, Italia Grenga, Jean-Marie Cuillerot, Berend Neuteboom, Anja von Heydebreck, Kevin M. Chin, Jeffrey Schlom, James L. Gulley
The Lancet Oncology. 2017299 CitationsOPEN ACCESS
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
James L. Gulley, Arun Rajan, David R. Spigel, Nicholas Iannotti, Jason C. Chandler, Deborah Jean Lee Wong, Joseph W. Leach, W. Jeff Edenfield, Ding Wang, H. Grote, Anja von Heydebreck, Kevin M. Chin, Jean-Marie Cuillerot, Karen Kelly
The Lancet Oncology. 2017286 CitationsOPEN ACCESS
Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial
Ariel López-Chávez, Anish Thomas, Arun Rajan, Mark Raffeld, Betsy Morrow, Ronan J. Kelly, Corey Allan Carter, Udayan Guha, Keith Killian, Christopher Lau, Zied Abdullaev, Liqiang Xi, Svetlana Pack, Paul S. Meltzer, Christopher L. Corless, Alan Sandler, Carol Beadling, Andrea Warrick, David J. Liewehr, Seth M. Steinberg, Arlene Berman, Austin Doyle, Éva Szabó, Yisong Wang, Giuseppe Giaccone
Journal of Clinical Oncology. 2015235 Citations
Related on ScholarIQ
National Institutes of Health
Institution
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
Paper
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
Paper
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial
Paper
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
Paper
Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial
Paper